These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 22911553)

  • 21. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
    Liebermann DA; Hoffman B
    Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations of the RAS genes in childhood acute myeloid leukemia, myelodysplastic syndrome and juvenile chronic myelocytic leukemia.
    Sheng XM; Kawamura M; Ohnishi H; Ida K; Hanada R; Kojima S; Kobayashi M; Bessho F; Yanagisawa M; Hayashi Y
    Leuk Res; 1997 Aug; 21(8):697-701. PubMed ID: 9379676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [EVI1 and its role in myelodysplastic syndrome, myeloid leukemia and other malignant diseases].
    Fuchs O
    Cas Lek Cesk; 2006; 145(8):619-24. PubMed ID: 16995417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the C-MYC amplicon in a case of acute myeloid leukemia with double minute chromosomes.
    Crossen PE; Savage LM; Heaton DC; Morrison MJ
    Cancer Genet Cytogenet; 1999 Jul; 112(2):144-8. PubMed ID: 10686942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines.
    Yokota S; Kiyoi H; Nakao M; Iwai T; Misawa S; Okuda T; Sonoda Y; Abe T; Kahsima K; Matsuo Y; Naoe T
    Leukemia; 1997 Oct; 11(10):1605-9. PubMed ID: 9324277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ecotropic virus integration site-1 gene preferentially expressed in post-myelodysplasia acute myeloid leukemia: possible association with GATA-1, GATA-2, and stem cell leukemia gene expression.
    Ohyashiki JH; Ohyashiki K; Shimamoto T; Kawakubo K; Fujimura T; Nakazawa S; Toyama K
    Blood; 1995 Jun; 85(12):3713-8. PubMed ID: 7780155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Oncogenes in hematopoietic malignancies and genetic diagnosis].
    Hirai H
    Nihon Rinsho; 1987 Dec; 45(12):2864-71. PubMed ID: 3328800
    [No Abstract]   [Full Text] [Related]  

  • 28. NKL homeobox gene activities in normal and malignant myeloid cells.
    Nagel S; Scherr M; MacLeod RAF; Pommerenke C; Koeppel M; Meyer C; Kaufmann M; Dallmann I; Drexler HG
    PLoS One; 2019; 14(12):e0226212. PubMed ID: 31825998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNAs in the pathogenesis of myelodysplastic syndromes and myeloid leukaemia.
    Song SJ; Pandolfi PP
    Curr Opin Hematol; 2014 Jul; 21(4):276-82. PubMed ID: 24870972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular abnormalities in myeloid leukemias and myelodysplastic syndromes.
    Sawyers CL
    Leuk Res; 1998 Dec; 22(12):1113-22. PubMed ID: 9922075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Translocation (12;17)(q13;q23) in de novo acute myeloid leukemia with trilineage myelodysplasia.
    Wong KF; So CC; Yu PH
    Cancer Genet Cytogenet; 1999 Oct; 114(2):159-61. PubMed ID: 10549276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The myelodysplastic/myeloproliferative disorders: the interface.
    Bennett JM
    Hematol Oncol Clin North Am; 2003 Oct; 17(5):1095-100, v. PubMed ID: 14560776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A sole del(15q) anomaly in post-myelodysplasia acute myeloid leukemia.
    Yahata N; Ohyashiki K; Iwase O; Kimura Y; Kodama A; Fukutake K; Toyama K
    Leuk Res; 1998 Sep; 22(9):845-7. PubMed ID: 9716017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote d'Or (Burgundy, France).
    Maynadié M; Girodon F; Manivet-Janoray I; Mounier M; Mugneret F; Bailly F; Favre B; Caillot D; Petrella T; Flesch M; Carli PM
    Haematologica; 2011 Jan; 96(1):55-61. PubMed ID: 20971817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnostic molecular pathology of lymphatic and myeloid neoplasms].
    Klapper W; Kreipe H
    Pathologe; 2015 Mar; 36(2):164-70. PubMed ID: 25809654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myeloid malignancies and chromosome 5 deletions.
    Westbrook CA; Keinänen MJ
    Baillieres Clin Haematol; 1992 Oct; 5(4):931-42. PubMed ID: 1339191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proto-oncogene expression and dissection of the myeloid growth to differentiation developmental cascade.
    Liebermann DA; Hoffman-Liebermann B
    Oncogene; 1989 May; 4(5):583-92. PubMed ID: 2471131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapy-related myeloid leukemia.
    Thirman MJ; Larson RA
    Hematol Oncol Clin North Am; 1996 Apr; 10(2):293-320. PubMed ID: 8707757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromosome 1 abnormalities in myeloid malignancies: a literature survey and karyotype-phenotype associations.
    Caramazza D; Hussein K; Siragusa S; Pardanani A; Knudson RA; Ketterling RP; Tefferi A
    Eur J Haematol; 2010 Mar; 84(3):191-200. PubMed ID: 20002154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of translocation-associated fusion genes of FGFRI, MYC, NPMI, and DEK, but absence of the translocations in acute myeloid leukemia. A microarray analysis.
    Larramendy ML; Niini T; Elonen E; Nagy B; Ollila J; Vihinen M; Knuutila S
    Haematologica; 2002 Jun; 87(6):569-77. PubMed ID: 12031912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.